New Metabolic Index Identified Insulin Resistance in Teens
Researchers found that the METS-IR index may help doctors better screen adolescents for insulin resistance and MASLD.
Updated on Sept. 28, 2026 in Children’s Health
Live Poll
Should new medical diagnostic research be integrated into standard clinical care as soon as possible?
A 2026 study of 257 adolescents suggests that the Metabolic Score for Insulin Resistance (METS-IR) can effectively identify insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD). These findings offer a potential new tool for clinicians as traditional markers often perform poorly during puberty.
Why it matters
Traditional metabolic screening tools often show inconsistent results in teenagers due to the hormonal changes of puberty. Identifying more accurate, non-invasive indices could help clinicians detect early signs of metabolic dysfunction and liver disease in young populations more reliably.
In a study of 257 adolescents, researchers evaluated the performance of METS-IR using receiver operating characteristic curve analysis. The index demonstrated a sensitivity of 52.9% and specificity of 94.7% for identifying insulin resistance, though these are preliminary findings needing prospective validation.
The details
The METS-IR index serves as a composite biomarker designed to estimate insulin sensitivity using routine clinical measurements. Researchers utilized multivariate logistic regression and Spearman correlation analysis to compare its performance against established markers like the TyG index. Because MASLD and insulin resistance are interconnected, this score helps capture metabolic risk factors that are often masked by the rapid physiological changes occurring during adolescence.
Timeline
The findings were published in 2026.
Health Landscape
This research follows the ongoing refinement of MASLD diagnostic criteria by investigating how adult-focused metabolic indices perform in younger populations. It specifically addresses the diagnostic gaps inherent in puberty, where hormonal shifts often render conventional testing markers less precise.
Parents and caregivers should note that these findings are preliminary and not yet a standard clinical diagnostic tool. If you have concerns about your child's metabolic health, discuss appropriate screening options and symptom patterns with your pediatrician.
The takeaway
While promising, the METS-IR index is still in the research phase and requires further confirmation before it can be used for clinical decision-making. Continue to monitor your child's overall metabolic profile through regular checkups and keep the conversation open with a qualified physician.
Further reading
For more on managing metabolic wellness, visit the Children’s Health section.
Source note: This article includes information reported by Nature.
Live Poll
Should new medical diagnostic research be integrated into standard clinical care as soon as possible?
